Title: | Real-World Evidence Generation in a Demanding Era | |
Date: | Monday, June 16 – Day 1 | |
Location: | Innovation Theatre #2 | |
Presenter: | Eric Schrock, Chief Technology Officer | |
Overview: |
As the demand for faster, more agile, and cost-effective evidence generation grows, traditional observational studies are showing their limitations-slow site activation, burdensome operations, and limited scalability. This session explores how automation and AI are modernizing approaches to real-world observational programs. Join us to discover how leading life sciences are using AI-powered real-world data solutions to streamline prospective studies, post-marketing commitments, and regulatory-required evidence generation. Learn how these technologies enable long-term, scalable, and diverse patient engagement while meeting the rigorous demands of regulatory authorities and supporting product differentiation in real-world settings. |
Meet the team
![]() Richard Gliklich, CEO, OM1 |
![]() Eric Schrock, Chief Technology Officer |
![]() Mark Hogendobler, Senior Director, RWE and AI Solutions Architect |
![]() Todd Price, Senior Director, Business Development |
![]() Jodi Silva, Marketing Manager |